Top news of the week: 29.09.2020.
#BioTech #healthcare #trading #investing #finance #stocks #covid19 #nasa #ux
Healthcare
RT @SeekingAlpha: Introducing The Global X China Biotech Innovation ETF. https://t.co/x3bFZiXF7i #finance #investing #trading
OpenIntroducing The Global X China Biotech Innovation ETF
With the rise of the broader health care sector, China's biotech industry is already among one of the fastest-growing in the world and is expected to mature from its infancy to a global ...
FDA Decisions For Mesoblast And Eton, Coronavirus Vaccine Updates #BioTech via https://t.co/2sI0UxJbpn https://t.co/QR2IjkGPbm
OpenThe Week Ahead In Biotech: FDA Decisions For Mesoblast And Eton, Coronavirus Vaccine Updates
Biotech stock reversed course last week, dragged lower by the broader market weakness. The week's news flow was headlined by Johnson & Johnson (NYSE: JNJ)...
Interesting article from Harry Wise at @MailOnline highlighting the British #healthcare sector's exciting investment opportunities including @ErgomedPLC, @AmrytPharmaPlc and @VecturaGroup that have all performed well since the start of the year
https://t.co/F153ZRkKdG
OpenAside from Covid-19, what lies ahead for British pharma firms?
Share prices of many British pharmaceutical firms have grown strongly despite a stock market-wide March dip.
California-Based Biotech Receives COVID-19 Trial Clearance: https://t.co/BMRoBfok45
The timeline and next steps for Equillium's proposed Phase 3 clinical study are outlined in an H.C. Wainwright & Co. report.
$EQ #covid19 #biotech #healthcare #stocks Equillium, Inc. https://t.co/NuXX4B6BH3
OpenCalifornia-Based Biotech Receives COVID-19 Trial Clearance Research Report
The timeline and next steps for Equillium's proposed Phase 3 clinical study are outlined in an H.C. Wainwright & Co. report.
Bharat Biotech inks deal with US-based varsity for single dose intranasal COVID vaccine #BioTech #nasa #ux via https://t.co/2sI0UxJbpn https://t.co/aVPkrRLFtp
OpenBharat Biotech Inks Deal With US-based Varsity For Single Dose Intranasal COVID Vaccine
Bharat Biotech would be making up to a billion doses of a single-dose intranasal COVID-19 vaccine in collaboration with Washington University School of Medicine
RT @HEFbharat: Bharat Biotech in pact with WUSM for intranasal chimp-adenovirus Covid-19 vaccine
https://t.co/D62x4kqeBl
OpenBharat Biotech in pact with WUSM for intranasal chimp-adenovirus Covid-19 vaccine
India Business News: Vaccine major Bharat Biotech has joined hands with inked a licensing agreement with the Washington University School of Medicine in St. Louis for dev
STAT Virtual Event: The ESMO Recap, Live!
STAT’s Adam Feuerstein joins top cancer experts to review the data presented at ESMO, and discuss what's ahead for cancer clinical trials.
Roche, AC Immune's tau-blocking drug flops in Alzheimer's as biotech's shares halved #BioTech via https://t.co/2sI0UxJbpn https://t.co/5vuZ3fJ8oP
OpenRoche, AC Immune's tau-blocking drug flops in Alzheimer's as biotech's shares halved
Blocking tau appears to be just as fruitless as clearing amyloid buildup when it comes to helping Alzheimer’s disease patients.